...Emilia Maggio; Antonio Peroglio Deiro; Maurizio Mete; Mauro Sartore; Antonio Polito; Guido Prigione; Massimo Guerriero; Grazia Pertile Purpose: To evaluate the effectiveness of recombinant tissue plasminogen activator (rtPA) and sulphur hexafluoride gas (SF 6 ) intravitreal injection...

...Elsbeth J.T. van Zeeburg; Jan C. van Meurs Aims: To review and discuss the literature on recombinant tissue plasminogen activator (rtPA) for the treatment of a recent-onset submacular hemorrhage in patients with age-related macular degeneration. Methods: The administration technique of rtPA...

...Detlef Holland; Burkhard Wiechens Aim: To present the technique and efficiency of intravitreal recombinant tissue plasminogen activator (r-TPA) and gas injection in acute submacular hemorrhage (SMH) due to traumatic choroidal rupture. Patients and Methods: 0.4 ml of sulfur hexafluoride was injected...

... Iron deficiency anemia Recombinant tissue plasminogen activator Retinal vascular resistance Nonarteritic ischemic optic neuropathy In the medical literature thus far, hemoglobin levels have been considerably decreased in only very few cases of retinal vessel occlusion in iron deficiency...

... separately investigated three different groups, depending on the following criteria: onset of symptoms within 11 days prior to admission and thrombolytic treatment with 50 mg of recombinant tissue plasminogen activator (rtPA) and intravenous heparinization (n = 23) or hemodilution therapy (n = 22) or onset...

... by the use of low-dose thrombolytic regimens. In our study, 14 patients with ischaemic central (CRVO) or branch (BRVO) retinal vein occlusion who presented with severe visual loss and recent onset of symptoms were treated with a low dose (50 mg) of recombinant tissue plasminogen activator (rt-PA...